Provided are a defibrillation catheter system, a defibrillation power supply device, and a method for controlling the device during observation of intracardiac potential and defibrillation. A defibrillation catheter system 1 includes a catheter 20; a first power supply part 6A and a second power supply part 6B connected to the catheter 20; and an electrocardiograph 40 measuring an intracardiac potential, wherein the catheter 20 is provided with a first electrode group 21 having at least a 1-1 electrode and a 1-2 electrode and a second electrode group 22 having at least a 2-1 electrode and a 2-2 electrode, the first and second electrode groups 21 and 22 are connected to the electrocardiograph 40, the 1-1 electrode and the 2-1 electrode are connected to the first power supply part 6A, and the 1-2 electrode and the 2-2 electrode are connected to the second power supply part 6B.

Techniques are disclosed for a multi-tier system for predicting cardiac arrhythmia in a patient. In one example, a computing device processes parametric patient data and provider data for a patient to generate a long-term probability that a cardiac arrhythmia will occur in the patient within a first time period. In response to determining that the cardiac arrhythmia is likely to occur within the first time period, the computing device causes a medical device to process the parametric patient data to generate a short-term probability that the cardiac arrhythmia will occur in the patient within a second time period. In response to determining that the cardiac arrhythmia is likely to occur within the second time period, the medical device performs a remediative action to reduce the likelihood that the cardiac arrhythmia will occur.

A lead-in-lead system may include a first implantable lead having a first electrode and a second implantable lead having a second electrode guided by the first implantable lead to an implantation site. The second electrode may be implanted in a patient's heart distal to the first electrode at the same implantation site or at a second implantation site. Various methods may be used to deliver the lead-in-lead system to one or more implantation sites including at the triangle of Koch for ventricle-from-atrium (VfA) therapy, at the right ventricular septal wall for dual bundle-branch pacing, or in the coronary vasculature for left side sensing and pacing.

Implantable devices, such as artificial organs, increasingly incorporate hardware, software, firmware, and/or wireless communication capabilities. For example, such implantable devices can utilize wireless technology to allow for efficient configuration, maintenance, and operational analysis. As these implantable devices become more connected, electronic security will become more important. This disclosure relates to implantable devices that may utilize a secure boot process and secure communication, both between artificial devices in the human body and between these devices and the external world. This disclosure provides secure communication approaches for maintaining the digital privacy and integrity of artificial devices, for protecting the individual from malicious hacking of data, and for controlling of such implantable devices.

A surgical method treats infections on a lead positioned at least partially within a patient's body. The surgical method includes uncoupling the lead from a pulse generator. The lead is then coupled to an ultrasound wave generator. Ultrasound waves are propagated from the ultrasound wave generator through the lead. Systems are disclosed.

Systems and methods for multi-site cardiac stimulation are disclosed. The system includes an electrostimulation circuit to deliver electrostimulation to one or more candidate sites of at least one heart chamber. The system may sense a physiological signal including during electrostimulation of the heart, use the physiological signal to determine a first stimulation vector for electrostimulation at a first left ventricular (LV) site and a second stimulation vector for electrostimulation at a different second LV site, and determine a therapy mode including a first chronological order and a first timing offset between stimulations delivered according to the first and second stimulation vectors. The electrostimulation circuit may deliver electrostimulation to the heart in accordance with the first and second stimulation vectors and the therapy mode.

An implantable electrical stimulating device and system provides for a remote determination of the identity of the person in whom the stimulating device is implanted. The stimulating device may be a pacemaker, a defibrillator, another medical device or a non-medical device. The bases for the remote identification are (1) the commingling of (A) biologic identification information of the person linked to the stimulating device, and (B) information pertaining to a physiologic parameter (e.g. heart rate information) of that person, and (2) the modulation of the physiologic parameter by external information. Embodiments of the invention in which the stimulating device is external to the person are possible. By utilizing the apparatus providing for the remote identification of a person plus stimulating device, one aspect of secure communication—that based on reliable mutual identification of each participant in a communication—is achieved.

An implantable medical device (IMD) can include implantable pulse generator (IPG) devices, implantable cardioverter-defibrillators (ICD), cardiac resynchronization therapy defibrillator devices, neurostimulators or combinations thereof. In one example, the IMD can include a body assembly, which can provide at least one electrical signal corresponding to a therapy. The IMD can also include a cardiac lead assembly, which can have a proximal portion and a distal portion. The proximal portion of the cardiac lead assembly can be in communication with the body assembly to receive the therapy and the distal portion can be adapted to be coupled to an anatomical structure to transmit the at least one electrical signal to the anatomical structure. The proximal portion of the cardiac lead assembly can have a first stiffness and the distal portion can have a second stiffness. The first stiffness can be greater than the second stiffness.

The defibrillating electrical apparatus is controlled such that the enabling signal generator generates an enabling signal for the (n+1)-th R wave (R.sub.n+1) when and after a first time interval (T.sub.1) as a time interval from the n-th R wave (R.sub.n) to the (n+1)-th R wave (R.sub.n+1) of an electrocardiographic waveform (50) exceeds a first predetermined time period, if the first time interval (T.sub.1) is equal to or less than the first predetermined time period, the defibrillating electrical apparatus is controlled such that the enabling signal generator generates an enabling signal for the (n+2)-th R wave (R.sub.n+2) when and after a second time interval (T.sub.2) as a time interval from the n-th R wave (R.sub.n) to the (n+2)-th R wave (R.sub.n+2) of an electrocardiographic waveform (50) exceeds a second predetermined time period.

In some examples, a coil electrode assembly includes a coil electrode including a plurality of windings and extending from an electrode proximal end to an electrode distal end, the coil electrode defining an electrode lumen from the electrode proximal end to the electrode distal end. The coil electrode assembly further includes an insulative tube extending within the lumen of the coil electrode such that the coil electrode extends along an outer surface of the insulative tube. The coil electrode is partially embedded within the insulative tube when the insulative tube is in an expanded state to maintain a spacing between the windings.